State Street’s Streamline Health Solutions STRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,781
Closed -$20K 4317
2024
Q3
$20K Hold
5,781
﹤0.01% 4227
2024
Q2
$40K Hold
5,781
﹤0.01% 4186
2024
Q1
$41.6K Sell
5,781
-1,927
-25% -$13.3K ﹤0.01% 4193
2023
Q4
$49.1K Hold
7,708
﹤0.01% 4202
2023
Q3
$112K Buy
7,708
+293
+4% +$5.09K ﹤0.01% 4087
2023
Q2
$141K Hold
7,415
﹤0.01% 4113
2023
Q1
$200K Hold
7,415
﹤0.01% 4083
2022
Q4
$176K Hold
7,415
﹤0.01% 4155
2022
Q3
$132K Hold
7,415
﹤0.01% 4334
2022
Q2
$141K Hold
7,415
﹤0.01% 4361
2022
Q1
$178K Buy
7,415
+294
+4% +$6.3K ﹤0.01% 4425
2021
Q4
$157K Hold
7,121
﹤0.01% 4444
2021
Q3
$187K Buy
7,121
+113
+2% +$2.79K ﹤0.01% 4377
2021
Q2
$186K Buy
+7,008
New +$209K ﹤0.01% 4234

Other funds holding STRM

State Street's STRM Position: Q4 2024 in Review

State Street sold out of Streamline Health Solutions (STRM) in Q4 2024, closing a stake of 5,781 shares — an estimated $20K sold.

State Street first reported a position in STRM in Q2 2021 and held it in 14 quarters. The position peaked at $200K in Q1 2023. 17 funds tracked by Wall St. Rank hold STRM as of Q4 2024.

  • State Street reported no remaining Streamline Health Solutions position as of Q4 2024 after selling out during the quarter.
  • State Street sold 5,781 Streamline Health Solutions shares in Q4 2024, an estimated $20K.
  • State Street first reported a position in Streamline Health Solutions in Q2 2021 and held it in 14 quarters.
  • State Street's Streamline Health Solutions position peaked at $200K in Q1 2023.
  • 17 funds tracked by Wall St. Rank held Streamline Health Solutions as of Q4 2024.

Based on State Street's 13F filing for Q4 2024, filed 14 Feb 2025.